Author

Leslie Todd

Observed names: LESLIE K. TODD, Leslie K. Todd, Todd, Leslie K.

Institution: Rigel (United States)

Observed institutions: Tulane University, University of Southern California, University of California, San Francisco, Vivus (United States), Rigel (United States), Albany Medical College, Saint Louis University

ORCID: 0000-0003-3801-9930

Observed ORCID: 0000-0003-3801-9930

OpenAlex ID: A5013549988

Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil

1997 · Harin Padma-Nathan, Wayne J.G. Hellstrom, et al. · New England Journal of Medicine · 575

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

1996 · Wayne J.G. Hellstrom, Alan H. Bennett, et al. · Urology · 76

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia

2020 · Ralph Boccia, Nichola Cooper, et al. · British Journal of Haematology · 73

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib

2021 · Nichola Cooper, Ivy Altomare, et al. · Therapeutic Advances in Hematology · 72

Erectile Response to Transurethral Alprostadil, Prazosin and Alprostadil-prazosin Combinations

1998 · CRAIG A. PETERSON, ALAN H. BENNETT, et al. · The Journal of Urology · 33

Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy

2023 · Frederick W.K. Tam, James Tumlin, et al. · Kidney International Reports · 20

Fostamatinib disodium hexahydrate: a novel treatment for adult immune thrombocytopenia.

2019 · Ali McBride, Pratima Nayak, et al. · PubMed · 6

Potential Anti-Thrombotic Effect without Accompanying Hemorrhage with Fostamatinib Use in Patients with Immune Thrombocytopenia

2019 · Ivy Altomare, Vadim V. Markovtsov, et al. · Blood · 5

Enhanced Responses to Fostamatinib As Second-Line Therapy and in Persistent Immune Thrombocytopenia (ITP) Patients

2019 · Ralph Boccia, Michael A. Boxer, et al. · Blood · 4

Real-World Experience with Fostamatinib for Treatment of Immune Thrombocytopenia (ITP): Patient-Reported Outcomes

2022 · James B. Bussel, John Hales, et al. · Blood · 3

Real-World Experience with Combination Therapy of Fostamatinib and Thrombopoetin Receptor Agonists (TPO-RAs) for Treatment of Immune Thrombocytopenia (ITP): Patient-Reported Outcomes

2024 · Elizabeth Bowhay-Carnes, Yuliya Kreychman, et al. · Blood · 2

P555: Olutasidenib in Post-venetoclax Patients With Mutant Idh1 Aml

2023 · Jorge Cortes, Justin M. Watts, et al. · HemaSphere · 1

Works count: 14

Citation count: 870

H-index: 6

I10-index: 6